BioCentury
ARTICLE | Clinical News

Nolasiban: Ph II data

November 4, 2016 7:54 PM UTC

Top-line data from the double-blind, European Phase II IMPLANT trial in 247 women undergoing embryo transfer following in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) showed th...

BCIQ Company Profiles

Merck KGaA

ObsEva S.A.

BCIQ Target Profiles

Oxytocin receptor